Menu
Currency
GWAS Study

Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population.

Hallberg P, Eriksson N, Ibañez L et al.

27157822 PubMed ID
GWAS Study Type
5209 Participants
30 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HP
Hallberg P
EN
Eriksson N
IL
Ibañez L
BE
Bondon-Guitton E
KR
Kreutz R
CA
Carvajal A
LM
Lucena MI
PE
Ponce ES
MM
Molokhia M
MJ
Martin J
AT
Axelsson T
YQ
Yue QY
MP
Magnusson PK
WM
Wadelius M
Chapter II

Abstract

Summary of the research findings

Drug-induced agranulocytosis is a potentially life-threatening adverse reaction. Genome-wide association studies (GWASs) in ethnic Chinese people in Taiwan and Hong Kong have shown an association between agranulocytosis induced by antithyroid drugs and the HLA alleles HLA-B*38:02 and HLA-DRB1*08:03. We aimed to identify genetic variants associated with antithyroid drug-induced agranulocytosis in a white European population.

38 European ancestry cases, 1 case, 5,170 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

5209
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Sweden, Germany, Spain, France
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.